(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas - Wikidata - awgldk - TriplyDB

(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas

(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas

http://www.wikidata.org/entity/Q28259782

about

Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes Imaging neuroinflammation in multiple sclerosis using TSPO-PET Neuroinflammatory component of gray matter pathology in multiple sclerosis Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [11C]-( R)-PK11195 PET and MRI.In vivo imaging of translocator protein, a marker of activated microglia, in alcohol dependence Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.Positron emission tomography imaging of coronary atherosclerosis.Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET.Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer's disease.Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain.Microglial depletion and activation: A [11C]PBR28 PET study in nonhuman primates.Imaging of microglial activation in MS using PET: Research use and potential future clinical application.The immune response of the human brain to abdominal surgery.Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Advances in positron emission tomography for the imaging of rheumatoid arthritis.(11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis.The macrophage marker translocator protein (TSPO) is down-regulated on pro-inflammatory 'M1' human macrophages.TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis.Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies.The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.[11 C]PBR-28 positron emission tomography in multiple sclerosis: Neuroinflammation or otherwise?Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography.Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects.

P2860

Q28078621-4EA45960-8560-4494-AB6D-DC57FA10E27C Q28084625-445D9727-4204-4CF3-955F-43B7F4CE7770 Q29398383-7006AC9E-E7A1-40EA-ABBC-5725D393C749 Q33624586-776D8156-BE08-4F60-92D7-A06DF15D74F2 Q33632167-29D53A02-D6A9-4EDA-B33F-EB6A22A33657 Q34680915-814AC238-193B-4ED4-9B96-FC6BAE18249F Q35853077-EAF4197B-A49B-4D6E-ADF9-18B2A90D6687 Q36155325-E2F98630-353D-4B60-90EA-DB7782DF29A2 Q37050963-8A23B778-5EEF-482C-8745-6C13D25AF152 Q37220627-ED49DEA7-5E15-434A-A39B-73D2F84087D2 Q37289910-05BDCE6B-A907-43AF-AD82-B84AEC29DC28 Q37306518-7D0D7450-06E7-4863-8F20-D9AADFD69AB3 Q38662992-CE602DA9-FFA7-454F-B3C6-5FDF3423AA4D Q38808948-81F53F96-C2DA-458C-AD1D-73F13470DD94 Q38933080-35E2C0E8-D725-4CAB-A670-C7602150C2A5 Q38949384-14CEBA20-985B-4048-8C4F-40CCEF766DD5 Q39127994-D36A4857-94AD-496B-B1AF-647FEBAFDF6A Q39137978-74C611FA-DEB0-4FE6-9A5F-4E1B95BE3D9D Q40965410-F0B0D9D2-C77C-409C-A7BD-28C2B1411770 Q41125322-ADFB187D-3AC7-458D-B7DA-53193C417A26 Q42368975-7E2549EA-730B-4ED5-846D-DBC38DA8BDF6 Q45363125-724C32EC-CAC8-4B68-9B3D-0276CC9A14C4 Q47979574-0F64B219-3ACD-42AD-96F6-BD6F4169B870 Q48168382-9B7E585E-6FBF-4922-92DB-9A3FBD8876BF Q48381598-ED39BADF-8E6A-449F-B791-EA79AD7610C4 Q52597663-F458EDAD-E2C4-42F0-9B38-1FC0673FBABF Q52663504-3EBA4E48-75A3-4A51-93E5-1AFE9576D437

P2860

(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas

http://www.wikidata.org/entity/Q28259782

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

(11)C-PBR28 imaging in multipl ...... n of active white matter areas

@ast

(11)C-PBR28 imaging in multipl ...... n of active white matter areas

@en

(11)C-PBR28 imaging in multipl ...... n of active white matter areas

@nl

type

label

(11)C-PBR28 imaging in multipl ...... n of active white matter areas

@ast

(11)C-PBR28 imaging in multipl ...... n of active white matter areas

@en

(11)C-PBR28 imaging in multipl ...... n of active white matter areas

@nl

prefLabel

(11)C-PBR28 imaging in multipl ...... n of active white matter areas

@ast

(11)C-PBR28 imaging in multipl ...... n of active white matter areas

@en

(11)C-PBR28 imaging in multipl ...... n of active white matter areas

@nl

P1433

Q28259782-369F8D1E-7392-4457-9D61-B931803D07E8

P1476

Q28259782-A14995CF-FF78-497D-9198-437A28C77C7B

P2093

Q28259782-149AED88-5598-4B05-8546-E38690E4BAA5

Q28259782-2105B12F-43A4-495E-A2F1-F6824AB8AD07

Q28259782-345A1C16-EAC2-4520-A628-07FB3A5A8B2B

Q28259782-4B375729-A031-44FA-93EA-C009C6144CE1

Q28259782-4D707CE7-F639-468A-8CE6-00AE04BE4F1D

Q28259782-5974EA8F-EC80-42DF-A271-D07B2D33E641

Q28259782-5B115777-F2BD-4EDF-80D6-3D8633CBA9A0

Q28259782-602BE655-D34E-49A1-9D4F-0B3EA17B6218

Q28259782-6C794D37-59DB-4D12-938A-AF8F552520F6

Q28259782-A8F40059-F7F8-4DF8-8908-630A002EECFF

P2860

Q28259782-05EAB417-6DA1-4F12-9C58-F49669645D63

Q28259782-0DA9D79B-A3C9-4BEF-AAC7-D888A504E8B6

Q28259782-0E5DD985-EF1A-4561-A4C8-88E21F6F81B6

Q28259782-150B73BF-94C9-4365-B40A-A2806B80412C

Q28259782-22B23989-906D-4F58-9985-B78611245913

Q28259782-265D6DF1-63FE-4653-8E6C-63D783DD7BEB

Q28259782-26F73D0D-8D21-4335-9B94-77F3B0CABC8B

Q28259782-27D47913-2935-404B-BCD0-48A157FD6260

Q28259782-29642C1E-607E-43EF-87C2-3E3EF880E55C

Q28259782-2E254D71-87CE-4179-BCEE-53AB0AB15C37

P2888

Q28259782-DEE6CDF8-661C-4C7A-BEDD-9914A7861EF2

P304

Q28259782-17E87208-2996-4C2F-8D32-3AC1ED5A1C04

P31

Q28259782-D7DCCE48-7191-42BA-8FA1-D40CAB3E02CF

P3181

Q28259782-A443F5FB-038A-4325-942C-F806CEBF4C20

P356

Q28259782-24C9A931-74C3-481A-A2B7-80FB4AE2C469

P407

Q28259782-88BA514F-83AD-45D7-B15A-3592438BF822

P433

Q28259782-AA9CE86D-2B90-45DE-9AA2-3A8179442E0A

P478

Q28259782-38B1283A-1B4A-4C67-B2EA-5BA26A21E8AD

P50

Q28259782-36E98CA7-680A-499F-B949-81764356EDE0

Q28259782-FFDA66E7-3CB2-40C4-B15D-BACFA942DD97

P577

Q28259782-F118C027-D006-4BEF-A875-A37548318DC0

P5875

Q28259782-D5BB3AE1-0B29-4A7B-8064-81CBA64DFEE5

P698

Q28259782-1CEBD2FD-33EA-4D21-8B37-C3533BF65815

P921

Q28259782-35A78427-7C97-46B1-B8DA-1F60946784B8

Q28259782-669B6C36-594E-4B9F-8152-43FCF3149087

Q28259782-8DF7F11F-B2B7-4E02-9D7A-E5348815A387

Q28259782-90F04B63-E3AE-46A7-B134-F0EA257ACF97

P3181

P356

S00259-015-3043-4

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

(11)C-PBR28 imaging in multipl ...... n of active white matter areas

@en

P2093

Anne Chastre

http://www.w3.org/2001/XMLSchema#string

Aracely Delgadillo

http://www.w3.org/2001/XMLSchema#string

Beata Planeta

http://www.w3.org/2001/XMLSchema#string

Daniel Pelletier

http://www.w3.org/2001/XMLSchema#string

David Leppert

http://www.w3.org/2001/XMLSchema#string

Jae-Yun Lee

http://www.w3.org/2001/XMLSchema#string

Jean-Dominique Gallezot

http://www.w3.org/2001/XMLSchema#string

Keunpoong Lim

http://www.w3.org/2001/XMLSchema#string

Kevin C O'Connor

http://www.w3.org/2001/XMLSchema#string

Ming-Kai Chen

http://www.w3.org/2001/XMLSchema#string

P2860

An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

Multiple sclerosis

Gray matter involvement in multiple sclerosis

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

Advances in functional and structural MR image analysis and implementation as FSL

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis.

Imaging neuronal and axonal degeneration in multiple sclerosis.

Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.

P2888

s00259-015-3043-4

P304

1081-1092

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3323686

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00259-015-3043-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274398205

http://www.w3.org/2001/XMLSchema#string

P698

25833352

http://www.w3.org/2001/XMLSchema#string

P921

reproducibility

multiple sclerosis